Refining Hormonal Diagnosis of Type II 3β-Hydroxysteroid Dehydrogenase Deficiency in Patients with Premature Pubarche and Hirsutism Based on HSD3B2 Genotyping
The DOI matches its Crossref record; 36 of the 43 references it cites were found in a registry or an index.
Abstract
Congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase/Δ5-Δ4-isomerase (3βHSD), a rare autosomal recessive disorder that affects both sexes, has a heterogeneous clinical presentation ranging from the severe salt-wasting to the non-salt-wasting forms and results from mutations in the HSD3B2 gene. The hormonal criteria for diagnosing the mild variant of 3βHSD deficiency have been controversial because the initial studies were not based on genetic evidence. We investigated the relationship between the hormonal phenotype and HSD3B2 genotype in 22 patients with clinical and/or biochemical features suggestive of 3βHSD2 deficiency, including nine female children with premature pubarche, 12 hirsute females, and one boy with salt-wasting and ambiguous genitalia. Serum 17-hydroxypregnenolone (Δ5-17P), cortisol (F), 17-hydroxyprogesterone, dehydroepiandrosterone, and androstenedione levels were determined by RIA and were compared with Tanner pubic hair stage-matched control groups. The genomic DNA was extracted, and the entire HSD3B2 gene was amplified by PCR followed by automatic sequencing. Besides two different mutations previously observed in three patients (T259M and G129R/P222Q mutations), we observed the P222Q mutation in the male patient with salt-wasting form of 3βHSD2 deficiency. Basal and ACTH-stimulated Δ5-17P levels (nanomoles per liter) ranged from 4–41 (−0.2 to 14 sd) and 36–97 (3.5–15.5 sd), respectively, in patients without mutation in HSD3B2 and from 69–153 (25–57 sd) and 201–351 (36–65 sd), respectively, in patients with mutation in HSD3B2. Basal and ACTH-stimulated Δ5-17P to F ratios ranged from 11–159 (0.5–25 sd) and 42–122 (2.4–11.3 sd), respectively, in patients without mutation in HSD3B2 and from 181-1700 (29–282 sd) and 487-1523 (52–167 sd), respectively, in patients with mutation in HSD3B2. The hormone findings in the genotype-proven patients suggest that the following hormonal criteria are compatible with 3βHSD2 deficiency in children with premature pubarche: ACTH-stimulated Δ5-17P and Δ5-17P to F ratios at or greater than 201 and 487 nmol/liter, respectively, equivalent to or greater than 36 and 52 sd above matched control mean. Basal and ACTH-stimulated Δ5-17P and Δ5-17P to F ratios in all genotype-proven patients in childhood were unequivocally higher than the levels of either genotype-normal patients. All the other parameters overlapped between the patients with and without mutations in the HSD3B2 gene. In conclusion, genotyping more patients in the present study, we confirm that patients with mutations in the HSD3B2 gene have extremely elevated basal and ACTH-stimulated Δ5-17P levels and Δ5-17P to F ratios. Therefore, these data refine the hormonal criteria proposed to predict more accurately 3βHSD2 deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Rhéaume, E., Lachance, Y., Zhao, H.-F., Breton, N., Dumont, M., Launoit, Y. D., Trudel, C., Luu-The, V., Simard, J., & Labrie, F. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1147 · Cited by 362
The, V. L., Lachance, Y., Labrie, C., Leblanc, G., Thomas, J. L., Strickler, R. C., & Labrie, F. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-8-1310 · Cited by 309
The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase
Bongiovanni, A. M. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104666 · Cited by 304
PANG, S., LERNER, A. J., STONER, E., LEVINE, L. S., OBERFIELD, S. E., ENGEL, I., & NEW, M. I. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-428 · Cited by 238
Rhéaume, E., Simard, J., Morel, Y., Mebarki, F., Zachmann, M., Forest, M. G., New, M. I., & Labrie, F. (1992) · Nature Genetics · doi:10.1038/ng0792-239 · Cited by 235
Genetic Defects of Steroidogenesis in Premature Pubarche*
TEMECK, J. W., PANG, S., NELSON, C., & NEW, M. I. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-3-609 · Cited by 152
Pubertal Presentation of Congenital Δ5–-3β–Hydroxysteroid Dehydrogenase Deficiency*
ROSENFIELD, R. L., RICH, B. H., WOLFSDORF, J. I., CASSORLA, F., PARKS, J. S., BONGIOVANNI, A. M., WU, C. H., & SHACKLETON, C. H. L. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-2-345 · Cited by 135
LACHANCE, Y., LUU-THE, V., VERREAULT, H., DUMONT, M., RHÉAUME, E., LEBLANC, G., & LABRIE, F. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.701 · Cited by 129
Lutfallah, C., Wang, W., Mason, J. I., Chang, Y. T., Haider, A., Rich, B., Castro-Magana, M., Copeland, K. C., David, R., & Pang, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8615 · Cited by 127
Research works printed but not linked: 1
- Chang, 1993, Hypothalamic-pituitary-gonadal function in pubertal male and female siblings with non-salt-losing classic 3β-hydroxysteroid dehydrogenase deficiency congenital adrenal hyperplasia., J Clin Endocrinol Metab, 7, 1251
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Premature adrenarche: novel lessons from early onset androgen excess
Idkowiak, J., Lavery, G. G., Dhir, V., Barrett, T. G., Stewart, P. M., Krone, N., & Arlt, W. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0223 · Cited by 158
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche
Ibáñez, L., Ong, K., Valls, C., Marcos, M. V., Dunger, D. B., & de Zegher, F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0336 · Cited by 135
“None of the girls had a family or personal history of diabetes mellitus or presented evidence for thyroid dysfunction, glucose intolerance (14), or late-onset congenital adrenal hyperplasia (15, 16), and none was receiving a medication known to affect gonadal function or carbohydrate metabolism.”
BackgroundCongenital adrenal hyperplasia and P450 oxidoreductase deficiency
Krone, N., Dhir, V., Ivison, H. E., & Arlt, W. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02740.x · Cited by 131
Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism
Ibáñez, L., Díaz, R., López-Bermejo, A., & Marcos, M. V. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9096-y · Cited by 106
Genetics of Congenital Adrenal Hyperplasia
Hannah-Shmouni, F., Chen, W., & Merke, D. P. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.008 · Cited by 97
Polycystic ovaries after precocious pubarche: relation to prenatal growth
Ibáñez, L., Jaramillo, A., Enríquez, G., Miró, E., López-Bermejo, A., Dunger, D., & de Zegher, F. (2007) · Human Reproduction · doi:10.1093/humrep/del395 · Cited by 84
“logical age; none of the girls presented evidence for late-onset congenital adrenal hyperplasia (New et al., 1983; Ibáñez et al., 1993; Mermejo et al., 2005).”
BackgroundMonogenic disorders of adrenal steroidogenesis
Baranowski, E. S., Arlt, W., & Idkowiak, J. (2018) · Hormone Research in Paediatrics · doi:10.1159/000488034 · Cited by 79
Al Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
46,XY DSD due to impaired androgen production
Mendonca, B. B., Costa, E. M. F., Belgorosky, A., Rivarola, M. A., & Domenice, S. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.003 · Cited by 78
Self-citationThe next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
Nonclassic adrenal hyperplasia
Speiser, P. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9097-x · Cited by 68
“Most cases of apparent lack of 3β-hydroxysteroid dehydrogenase deficiency based on relative elevation of δ5 steroids such as pregnenolone and dehydroepiandrosterone have not been borne out by genotype analysis of HSD3B2 [1, 2 ]. Similarly, there have been only isolated reports of late-onset 11-hydroxylase deficiency c…”
BackgroundFiet, J., Bouc, Y. L., Guechot, J., Hélin, N., Maubert, M.-A., Farabos, D., & Lamazière, A. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1048 · Cited by 80
“the other reported steroids (Table 5), agrees with previously published data [36].”
ResultCongenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
Gonçalves, J., Friães, A., & Moura, L. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000300 · Cited by 60
Baronio, F., Ortolano, R., Menabò, S., Cassio, A., Baldazzi, L., Natale, V. D., Tonti, G., Vestrucci, B., & Balsamo, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184605 · Cited by 60
Classic congenital adrenal hyperplasia and its impact on reproduction
Gomes, L. G., Bachega, T. A. S. S., & Mendonca, B. B. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.11.037 · Cited by 58
Self-citationTopor, L. S., Asai, M., Dunn, J., & Majzoub, J. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0692 · Cited by 57
Combined Low-Dose Pioglitazone, Flutamide, and Metformin for Women with Androgen Excess
Ibáñez, L., López-Bermejo, A., del Rio, L., Enríquez, G., Valls, C., & de Zegher, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2684 · Cited by 51
“Exclusion criteria were evidence of thyroid dysfunction, Cushing’s syndrome or hyperprolactinemia; glucose intolerance (15); personal history of diabetes mellitus; late-onset adrenal hyperplasia (16, 17); anemia; abnormal serum electrolytes; abnormal screening results for liver or kidney function; or abnormal echocard…”
BackgroundThe Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Nonclassic Congenital Adrenal Hyperplasia
Jha, S., & Turcu, A. F. (2021) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.10.008 · Cited by 65
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Ladjouze, A., Donaldson, M., Plotton, I., Djenane, N., Mohammedi, K., Tardy-Guidollet, V., Mallet, D., Boulesnane, K., Bouzerar, Z., Morel, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.867073 · Cited by 42
Update on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Welzel, M., Wüstemann, N., Ŝimić-Schleicher, G., Dörr, H. G., Schulze, E., Shaikh, G., Clayton, P., Grötzinger, J., Holterhus, P., & Riepe, F. G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1874 · Cited by 38
The classic and nonclassic concenital adrenal hyperplasias
Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14474.ra · Cited by 35
Witchel, S. F., & Topaloglu, A. K. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00017-2 · Cited by 35
Novel Mutations inCYP11B1Gene Leading to 11β-Hydroxylase Deficiency in Brazilian Patients
Soardi, F. C., Penachioni, J. Y., Justo, G. Z., Bachega, T. A. S. S., Inácio, M., Mendonca, B. B., de Castro, M., & de Mello, M. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2521 · Cited by 32
“Serum cortisol, 17-hydroxyprogesterone, 11-deoxycortisol, dehydroepiandrosterone, and 4-androstenedione levels were determined by RIA (11, 12).”
MethodSelf-citationAchermann, J. C., & Hughes, I. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00023-7 · Cited by 41
Diagnosis of Diseases of Steroid Hormone Production, Metabolism and Action
Honour, J. W. (2009) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v1i5.209 · Cited by 32
Clinical and molecular review of atypical congenital adrenal hyperplasia
Sahakitrungruang, T. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.1.1 · Cited by 30
Nordenström, A., Forest, M. G., & Wedell, A. (2007) · Hormone Research in Paediatrics · doi:10.1159/000102593 · Cited by 38
Ibáñez, L., Valls, C., & de Zegher, F. (2006) · Human Reproduction · doi:10.1093/humrep/dei329 · Cited by 28
“…on the Diagnosis and Classification of Diabetes Mellitus, 1997); family or personal history of diabetes mellitus; late-onset congenital adrenal hyperplasia (New et al., 1983; Mermejo et al., 2005); anaemia; abnormal serum electrolytes; and abnormal screening results for liver and kidney function.”
BackgroundJeandron, D. D., & Sahakitrungruang, T. (2012) · Hormone Research in Paediatrics · doi:10.1159/000336004 · Cited by 27
Donadille, B., Houang, M., Netchine, I., Siffroi, J., & Christin‐Maître, S. (2018) · Endocrine Connections · doi:10.1530/ec-17-0306 · Cited by 28
Congenital adrenal hyperplasia
Demirci, C., & Witchel, S. F. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00216.x · Cited by 24
“A blood sample for progesterone, 17-OHP, 17-hydroxypregnenolone, DHEA, androstenedione, and cortisol should be obtained prior to the Cortrosyn stimulation and either 30 or 60 minutes after the Cortrosyn.”
BackgroundInfluentialPediatric Disorders of Sex Development
Achermann, J. C., & Hughes, I. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00023-x · Cited by 29
Yang, M., & White, P. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae535 · Cited by 20
“Mutations in HSD3B2 cause a rare form of CAH, characterized by elevated ratios of Δ 5 / Δ 4 steroids, notably 17OHPreg/17OHP, that are > 8 SD above normal (44, 45).”
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Fraser, R., Gower, D. B., Honour, J. W., Ingram, M. C., Kicman, A. T., Makin, H. L. J., & Stewart, P. M. (2010) · Springer eBooks · doi:10.1023/b135931_5 · Cited by 19
Coeli‐Lacchini, F. B., Turatti, W., Elias, P. C. L., Elias, L. L. K., Martinelli, C. E., Moreira, A. C., Antonini, S. R. R., & de Castro, M. (2013) · Gene · doi:10.1016/j.gene.2013.03.082 · Cited by 18
Self-citationLusa, A. L. G., de Lemos‐Marini, S. H. V., Soardi, F. C., Ferraz, L. F. C., Guerra‐Júnior, G., & de Mello, M. P. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000800018 · Cited by 16
3?-hydroxysteroid dehydrogenase type II deficiency on newborn screening test
de Araújo, V. G. B., Oliveira, R., Gameleira, K. P. D., Cruz, C. B., & Lofrano‐Porto, A. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003098 · Cited by 15
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Glucocorticoid Resistance in Premature Adrenarche and PCOS: From Childhood to Adulthood
Panayiotopoulos, A., Bhangoo, A., Khurana, D., Ten, S., Michl, J., & Ghanny, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa111 · Cited by 15
“During the initial investigation of PA, it is important to rule out central precocious puberty, congenital adrenal hyperplasia (CAH) [12], virilizing tumors, Cushing as well as McCune Albright syndromes, cases of activating LH receptor and exogenous hormone exposures [13], inactivating PAPS synthase type 2 mutation [1…”
BackgroundMutation of HSD3B2 Gene and Fate of Dehydroepiandrosterone
Baquedano, M. S., Guercio, G., Costanzo, M., Marino, R. M., Rivarola, M. A., & Belgorosky, A. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.05.002 · Cited by 14
Ong, K. K., de Zegher, F., López‐Bermejo, A., Dunger, D. B., & Ibáñez, L. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0261 · Cited by 15
“None of the girls had a family or personal history of diabetes mellitus or presented evidence for thyroid dysfunction, Cushing syndrome, hyperprolactinaemia, glucose intolerance (31), late-onset congenital adrenal hyperplasia (32, 33 ) or clinical signs or symptoms of androgen excess (34, 35); none was receiving an oe…”
BackgroundTreatment Outcomes in Congenital Adrenal Hyperplasia
Cheng, T. Q., & Speiser, P. (2012) · Advances in Pediatrics · doi:10.1016/j.yapd.2012.04.009 · Cited by 9
“The type II 3bHSD gene (HSD3B2) is located on chromosome 1p11-13 and is expressed primarily in the adrenals and gonads [12,13].”
BackgroundGortakowski, M., Conroy, R., Aguiar, L., & Allen, H. (2016) · Clinical Case Reports · doi:10.1002/ccr3.742 · Cited by 8
Diagnostic approach in 46, XY DSD: an endocrine society of bengal (ESB) consensus statement
Baidya, A., Basu, A. K., Bhattacharjee, R., Biswas, D., Biswas, K., Chakraborty, P. P., Chatterjee, P., Chowdhury, S., Dasgupta, R., Ghosh, A., et al. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0515 · Cited by 11
Assessing the Function of the Human Adrenal Cortex
Flück, C. E. (2011) · KARGER eBooks · doi:10.1159/000327417 · Cited by 9
3β-Hydroxysteroid Dehydrogenase Deficiency
Morel, Y., Roucher‐Boulez, F., Plotton, I., Simard, J., & Coll, M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00008-9 · Cited by 12
López‐Bermejo, A., Casano, P., Petry, C. J., Jaramillo, A. M. A., Rodríguez‐González, F., Dunger, D. B., de Zegher, F., & Ibáñez, L. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02914.x · Cited by 9
Teasdale, S., & Morton, A. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0348 · Cited by 6
Hypoglycemia due to 3β-hydroxysteroid dehydrogenase type II deficiency in a newborn
Konar, M. C., Goswami, S., Babu, B., & Mallick, A. (2015) · Indian Pediatrics · doi:10.1007/s13312-015-0758-z · Cited by 5
“Decreased mineralocorticoid secretion in 3β-HSD deficiency results in varying degrees of salt wasting in both sexes and deficient androgen production causes ambiguous genitalia in males [6,7].”
BackgroundАдреногенітальний синдром: молекулярні механізми розвитку
Pishak, V. P., & Ryznychuk, М. О. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.13.2.2017.100612 · Cited by 5
Causas raras de pseudo-hermafroditismo feminino: quando suspeitar?
de Castro, M., & Elias, L. L. K. (2005) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302005000100017 · Cited by 7
Self-citationBlocs enzymatiques précoces de la surrénale
Samara‐Boustani, D., Bachelot, A., Pinto, G., Thibaud, E., Polak, M., & Touraine, P. A. (2008) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(08)40173-7 · Cited by 6
Rare forms of congenital adrenal hyperplasia: pathogenesis, clinical, treatment and management
Cavarzere, P., lupieri, V., battiston, R., Mancioppi, V., & Maffeis, C. (2025) · Journal of Endocrinological Investigation · doi:10.1007/s40618-025-02750-x · Cited by 5
Leka-Emiri, S., Taibi, L., Mavroeidi, V., Vlachopapadopoulou, E. A., Kafetzi, M. L., Michalacos, S., & de Roux, N. (2021) · Sexual Development · doi:10.1159/000519062 · Cited by 4
Congenital adrenal hyperplasia
Krone, N. P. (2011) · doi:10.1093/med/9780199235292.003.0616 · Cited by 3
3β-Hydroxysteroid dehydrogenase deficiency
Roucher‐Boulez, F., Morel, Y., Ladjouze, A., Plotton, I., Simard, J., & Coll, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-821424-4.00005-8 · Cited by 3
Advances on related genes with sexual precocity in mammals
Chu, M., Feng, T., Di, R., Zhang, B., & Zhang, Y. (2009) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2009.00013 · Cited by 2
Disorders of the Adrenal Gland
Fechner, P. Y. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00096-6 · Cited by 3
Polycystic Ovarian Syndrome: A Diagnosis of Exclusion
Wolf, J., Barnes, C., & Aubuchon, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8394-6_2 · Cited by 4
Bahillo-Curieses, P., de Trocóniz, L. L. F., López, A. D. C., & Martínez-Sopena, M. J. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.04.005 · Cited by 2
Bahillo-Curieses, P., de Trocóniz, L. L. F., López, A. D. C., & Martínez-Sopena, M. J. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.04.004 · Cited by 2
Disorders of the Adrenal Gland
Nimkarn, S., & New, M. I. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0134-0.10091-5 · Cited by 3
Disorders of the Adrenal Gland
Fechner, P. Y. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00084-2 · Cited by 1
Chagas, N. B., Moreira, A. C., de Castro, M., & Antonini, S. R. R. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag162
Self-citationRare Forms of Congenital Adrenal Hyperplasia Affecting Electrolyte Homeostasis
Antonini, S. R. R., & Luciano, T. M. (2023) · Endocrinology · doi:10.1007/978-3-030-44628-4_10-1 · Cited by 1
Disorders of Testosterone Synthesis
Sugandhi, N. (2024) · Springer eBooks · doi:10.1007/978-981-97-1639-5_25 · Cited by 1
Congenital Adrenal Hyperplasia (CAH): Definition and Enzymatic Defects in Various Forms
Keleştimur, F., & Ünlühızarcı, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-82591-1_1 · Cited by 4
Rare Forms of Congenital Adrenal Hyperplasia Affecting Electrolyte Homeostasis
Antonini, S. R. R., & Luciano, T. M. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_10 · Cited by 1
ez, L. I., Valls, C., & de Zegher, F. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000228702.83347.66
Non-classic congenital adrenal hyperplasia. Clinical experience versus clinical guidelines
SHAH, A. S., & Backeljauw, P. F. (2011) · Endocrinology Studies · doi:10.4081/es.2011.e11
revisão Causas Raras de Pseudo-Hermafroditismo Feminino: Quando Suspeitar?
de Castro, M., & Elias, L. L. K. (2005)
Self-citationNationellt miljökvalitetsmål på lokal nivå
Engkvist, F. (2011)
Polycystic ovaries after precocious pubarche: relation to prenatal growth
de Déu, S. J. (2007)
Delai, A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2022.tde-06052022-161625 · Cited by 1
(2012) · Elsevier eBooks · doi:10.1016/b978-3-437-41797-9.16001-7
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00004-8
Honour, J. W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-818124-9.00018-8
Disorders of Adrenal Steroid Biosynthesis Defects
He, X., & Auchus, R. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822563-9.00216-x · Cited by 1
46, XX DSD with Atypical Genitalia: Clinical Insights and Diagnostic Approaches
Karlekar, M. P., Sarathi, V., Barnabas, R., Lila, A. R., Memon, S. S., Shah, N. S., & Bandgar, T. (2025) · Hormone and Metabolic Research · doi:10.1055/a-2538-3603
Metadata
- Authors
- Mermejo, L. M., Elias, L. L. K., Marui, S., Moreira, A. C., Mendonca, B. B., & de Castro, M.
- Affiliations
- Departamento de Clinica Medica (L.M.M., A.C.M., M.d.C.) Brazil 14049-900;
- Universidade de São Paulo (BR)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03-01
- Volume
- 90
- Issue
- 3
- Pages
- 1287-1293
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2018930069
- Semantic Scholar
- f68cc6e7c1825c75345e9aeef2fc7e1d7528b96d
- Cited by
- 91
- References
- 43
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 5 · 2020: 1 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- 3β-hydroxysteroid dehydrogenase deficiency, congenital adrenal hyperplasia, premature pubarche, hirsutism, 17-hydroxypregnenolone, ACTH stimulation test, salt-wasting form, ambiguous genitalia, genotype-phenotype correlation
- MeSH terms
- Adolescent, Adult, Androstenedione, Child, Child, Preschool, Dehydroepiandrosterone, Female, Genetic Testing, Genotype, Hirsutism, Humans, Hydrocortisone, 17-alpha-Hydroxypregnenolone, Infant, Male, Predictive Value of Tests, Puberty, Precocious, 3-Hydroxysteroid Dehydrogenases, Point Mutation, 17-alpha-Hydroxyprogesterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.